Sitra

Headai Ltd. is a Finnish company founded in 2015 that specializes in developing software robots designed to automate intellectual tasks across various business operations. The company offers teachable robots as a cloud service, enabling organizations to streamline repetitive processes and enhance efficiency. Headai's technology combines natural language processing, reinforcement learning, and insights from cognitive sciences to create interactive and reliable bots that can learn quickly and adapt to user needs. Additionally, Headai provides tools for discovering relevant content and accessing information tailored to individual interests, thereby supporting corporate learning and decision-making. By leveraging its proprietary algorithms, Headai helps clients uncover valuable insights from large datasets, facilitating a better understanding of complex information.

VisionPlus is a Finnish venture capital firm established in 2011, located in Helsinki. The firm focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment portfolio encompasses software-as-a-service, mobile applications, and internet services, as well as special content intellectual property deals. The management team at VisionPlus possesses extensive experience in technology, entrepreneurship, and seed investments, having successfully developed and managed large-scale business and development organizations in a global context.

Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim specializes in non-invasive brain stimulation technologies, focusing on navigated transcranial magnetic stimulation (TMS) for therapeutic and diagnostic applications. Its proprietary SmartFocus technology enables accurate targeting of specific brain areas. Nexstim's primary products are the NBT system for treating major depression or chronic pain, and the NBS system for pre-surgical brain mapping. Headquartered in Helsinki, Finland, Nexstim serves customers globally.

Nexstim specializes in non-invasive brain stimulation technologies, focusing on navigated transcranial magnetic stimulation (TMS) for therapeutic and diagnostic applications. Its proprietary SmartFocus technology enables accurate targeting of specific brain areas. Nexstim's primary products are the NBT system for treating major depression or chronic pain, and the NBS system for pre-surgical brain mapping. Headquartered in Helsinki, Finland, Nexstim serves customers globally.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.